deal time?, page-15

Shareholders need to understand the magnitude of what it WOULD/WILL mean IF/WHEN Anteo sign with a company like Philips. Alere, Life Tech etc etc

A deal with Philips for instance would be massive validation and global exposure and the opportunity to get Mixngo involved from Day 1 on a Gold Standard POC device.

To give some example of market potential just for Philips and the Magnotech device - The Troponin test which has been mentioned as one of primary interest of Biomerieux and Philips has annual sales in the USA alone of $650m +.

The cartridges are disposable and would give ADO royalty revenue on every test ever done.

I am envisaging a Philips deal to be worth at full steam anywhere from $15-$30m pa to ADO

Life Technologies - Is the big boy when it comes to supplying the global major IVD companies - They have in excess of $500m in sales of beads to the majors so I am thinking somewhere from $20m - $40m pa at full scale for a deal that would see Mixngo on over half of the global IVD markets beads and the majority of the Top 10.

Throw in another 10 or 20 smaller deals... You decide

Even the announcement of an initial partnership with any of these key companies pre revenues would set this thing alight